Concepedia

Matthias Luz

ML

Statistics

Publications

14

Citations

1.6K

H-Index

13

Active since

1990

Affiliations

MedGenesis Therapeutix (Canada)(Current)

University of Bristol

Renishaw (United Kingdom)

University of California, San Francisco

North Bristol NHS Trust

Matthias Luz is an author at MedGenesis Therapeutix (Canada) specializing in medicine, pharmacology, and high-grade gliomas.

ORCID

Top concepts

Publications per year

1990–2020

14

Publications

14

Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia

Andreas Greinacher, Uwe Janssens, Günther Berg et al. · Circulation · 1999 · 341 citations · Full text

Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range

Andreas Greinacher, Petra Eichler, Norbert Lübenow et al. · Blood · 2000 · 302 citations

Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range

Andreas Greinacher, Petra Eichler, Norbert Lübenow et al. · Blood · 2000 · 292 citations

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease

Alan Whone, Matthias Luz, M Boca et al. · Brain · 2019 · 271 citations · Full text

Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease

Alan Whone, M Boca, Matthias Luz et al. · Journal of Parkinson s Disease · 2019 · 127 citations · Full text

1–5 of 14